• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[博来霉素与放疗联合治疗后肩部硬皮病]

[Scleroderma of the shoulders after treatment with combined bleomycin and radiotherapy].

作者信息

Marck Y, Meunier L, Barnéon G, Meynadier J

机构信息

Service de Dermatologie-Allergologie-Photobiologie, Hôpital St-Charles, Montpellier.

出版信息

Ann Dermatol Venereol. 1994;121(10):712-4.

PMID:7540814
Abstract

INTRODUCTION

There are many causes of scleroderma. We observed a case of scleroderma involving the shoulder and neck area after combined bleomycin and radiotherapy.

CASE REPORT

After six cycles of a CHOP-bleo protocol followed by radiotherapy for lymph node lymphoma, a female patient presented scleroderma involving the shoulders and neck area. Total bleomycin dose was 252 mg.

DISCUSSION

Among the imputable factors, particularly extrinsic factors, in a series of 33 cases of different chemotherapy protocols published by Peters et al. in 1988, we retained the bleomycin radiotherapy administration sequence as the cause of this complication. Given after bleomycin, radiotherapy could increase the risk of scleroderma.

摘要

引言

硬皮病有多种病因。我们观察到1例在使用博来霉素联合放疗后出现肩部和颈部硬皮病的病例。

病例报告

一名女性患者在接受CHOP-博来霉素方案6个周期治疗后,接着进行淋巴结淋巴瘤放疗,之后出现累及肩部和颈部的硬皮病。博来霉素总剂量为252毫克。

讨论

在彼得斯等人于1988年发表的一系列33例不同化疗方案中,在可归咎因素中,尤其是外在因素方面,我们认定博来霉素与放疗的给药顺序是导致这一并发症的原因。放疗在博来霉素之后使用,可能会增加硬皮病的风险。

相似文献

1
[Scleroderma of the shoulders after treatment with combined bleomycin and radiotherapy].[博来霉素与放疗联合治疗后肩部硬皮病]
Ann Dermatol Venereol. 1994;121(10):712-4.
2
Treatment results of tonsillar lymphoma: a 10-year experience.扁桃体淋巴瘤的治疗结果:十年经验
Ann Hematol. 2005 Apr;84(4):223-6. doi: 10.1007/s00277-004-0860-0. Epub 2004 Mar 23.
3
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.I-II期惰性非霍奇金淋巴瘤综合治疗前瞻性研究的长期随访
J Clin Oncol. 2003 Jun 1;21(11):2115-22. doi: 10.1200/JCO.2003.07.111.
4
Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.联合治疗原发性纵隔B细胞淋巴瘤:传统化疗与强化化疗对比
Ann Hematol. 2002 Jul;81(7):368-73. doi: 10.1007/s00277-002-0473-4. Epub 2002 Jun 21.
5
Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio Linfomi.长春花碱、博来霉素和甲氨蝶呤化疗联合放疗用于早期预后良好的霍奇金淋巴瘤患者:意大利淋巴瘤研究组的经验
Cancer. 2003 Dec 1;98(11):2393-401. doi: 10.1002/cncr.11807.
6
European experience with ifosfamide in lymphomas.欧洲使用异环磷酰胺治疗淋巴瘤的经验。
Semin Oncol. 1989 Feb;16(1 Suppl 3):73-7.
7
Treatment of patients with advanced or bulky Hodgkin disease with a 12-week doxorubicin, bleomycin, vinblastine, and dacarbazine-like chemotherapy regimen followed by extended-field, full-dose radiotherapy: long-term results of the Groupe Ouest et Est des Leucémies et Autres Maladies de Sang H90-A/B Multicenter Randomized Trial.
Cancer. 2002 Nov 15;95(10):2169-79. doi: 10.1002/cncr.10932.
8
[Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].采用ProMACE-CytaBOM方案治疗侵袭性非霍奇金淋巴瘤
Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):345-8.
9
[Clinical outcomes in low grade follicular lymphoma].
Rinsho Ketsueki. 1999 Jan;40(1):1-8.
10
[Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases].[局限性难治性非霍奇金淋巴瘤的同步放化疗——两例报告]
Gan To Kagaku Ryoho. 2007 Jan;34(1):125-8.